The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Overdosage
Limited data are available with regard to overdosage in human patients treated with Vericiguat (Verquvo). In VICTORIA, doses up to 10 mg have been studied. In a study of patients with preserved ejection fraction heart failure (left ventricular ejection fraction ≥45%), multiple doses of vericiguat 15 mg have been studied and were generally well tolerated. In the event of an overdose, hypotension may result. Symptomatic treatment should be provided. Vericiguat (Verquvo) is unlikely to be removed by hemodialysis because of high protein binding.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
